Green Matters on MSN7mon
Neffy, the Needle-Free Alternative to EpiPen, Earns FDA Approval — Here's What It Will Cost YouThose who rely on EpiPens during an allergic reaction may have a new alternative to reach for, after the U.S. Food and Drug ...
The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in children aged 4 and above. This is the first emergency allergy treatment ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...
“If approved, neffy would represent the first-ever needle-free nasal spray epinephrine treatment for people with severe allergic reactions that has been shown to be more easily carried and ...
“The neffyinSchools program will help eligible schools to obtain epinephrine free of cost. This better prepares schools to provide emergency treatment with a needle-free nasal epinephrine spray ...
The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...
Viatris Inc., formerly called Mylan, settled a class action lawsuit alleging that they were in a scheme to monopolize the market for the life-saving medication Julie Mazziotta is the Senior Sports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results